PHS
TERN

PFM Health Sciences’s Terns Pharmaceuticals TERN Stock Holding History

PFM Health Sciences’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.12M Buy
+172,962
New +$7.1M 0.83% 40
2021
Q2 		– Sell
-329,274
Closed -$7.24M – 97
2021
Q1 		$7.24M Buy
+329,274
New +$7.22M 0.22% 74

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

PFM Health Sciences's TERN Position: Q1 2026 in Review

PFM Health Sciences opened a new position in Terns Pharmaceuticals (TERN) in Q1 2026: 172,962 shares worth $9.12M. The stake represents 0.83% of the portfolio and ranks #40 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in TERN as recently as Q1 2021.

PFM Health Sciences first reported a position in TERN in Q1 2021 and has held it in 2 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • PFM Health Sciences held 172,962 shares of Terns Pharmaceuticals worth $9.12M as of Q1 2026.
  • Terns Pharmaceuticals was a new PFM Health Sciences position in Q1 2026.
  • Terns Pharmaceuticals made up 0.83% of PFM Health Sciences's portfolio in Q1 2026, its #40 holding.
  • PFM Health Sciences first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 2 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.